Kelley Lynne E 4
4 · X4 Pharmaceuticals, Inc · Filed Apr 26, 2019
Insider Transaction Report
Form 4
Kelley Lynne E
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2019-04-24+37,170→ 37,170 totalExercise: $20.30Exp: 2029-04-24→ Common Stock (37,170 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on April 24, 2020, with the remainder vesting in equal installments of 2.083% of the shares subject to the option on the last day of each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.